Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced that it has entered into a settlement agreement with Actavis Laboratories FL (“Actavis”) resolving patent litigation related …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced that, due to the impending loss of exclusivity of TREXIMET® (sumatriptan and naproxen sodium), the Company is …
Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) announced that Dr.
